Team

Our team combines deep technology and therapeutics expertise with strong operational and commercial experience.

Dr. Debora Lucarelli, Chief Executive Officer

Debora has a wealth of experience in technology development and a strong track record of successfully delivering large-scale projects in academia and industry. Previously, she led a cancer signature discovery program at Cambridge Epigenetix, directed laboratory research in large population studies (Head of laboratory, MRC Epidemiology, University of Cambridge) and worked on the development of the Oxford Nanopore’s technology. At Enhanc3D Genomics Debora is driving development of the technical platforms, establishing partnerships across the pharma and biotech industry and advocating the advent of a 3D genomics era.

Peter Bream, Chief Financial Officer

Peter has over 30 years of experience in international business ranging from start-ups to blue-chip companies. He has previously been CFO of public companies listed on the LSE and NASDAQ, in a range of industries including pharmaceuticals, medical diagnostics, engineering and chemicals with market capitalisations ranging from $10 million to $2 billion. Peter is currently a Non-Executive Director and Chair of the audit committee for an AIM listed healthcare business.

Dr. Nic Walker, Chief Technology Officer

Nic has 20 years of experience extracting and developing tools for insight from complex datasets in biotech, research institutes, and start-ups. His domain expertise crosses epigenomics, molecular technology development, cancer diagnostics, software engineering and machine learning. Prior to joining Enhanc3D Genomics Nic conducted research at the University of Cambridge in Epigenomics and was the Director of Data Science at Cambridge Epigenetix Ltd.

Dr. Stefan Schoenfelder, Chief Scientific Officer

Stefan is a recognised expert in the area of 3D genome organisation and function. Having led the development of Capture Hi-C while working in Prof. Fraser’s laboratory, Stefan is a group leader in the Epigenetics Programme at the Babraham Institute. He co-founded Enhanc3D in 2020 and continues to serve as CSO.

Hazel Jones, Chief Operating Officer

Hazel has significant oncology research experience, both in pharma/biotech and academic/charity sectors. She has a focus on long term strategic planning, both of logistics and scientific deliverables, as well as driving operational change. Hazel brings with her a broad understanding of all stages of drug development. We look forward to Hazel joining the C-Suite, driving the growth of the company.

View team

Dr. Lyubomira Chakalova, Senior Scientist

Lyubomira has over 20 years of experience in cutting-edge methodology development in molecular and cellular biology. Before joining Enhanc3D, Lyubomira worked in the Fraser group at Babraham for 10 years and previously led her own independent research group. At Enhanc3D Lyubomira is focused on maximising the value of the Company’s technology.

Alex Scott-Simons, Head of Bioinformatics Engineering

After initially training in Chemistry, Alex held a range of hands-on and management positions across data science and data engineering. He has built commercially successful data science products from scratch and gained global experience at high-profile companies (including Facebook, Lazada, and WPP) in consumer and advertising technology before returning to science and joining Enhanc3D.

Anne Rone, HR Manager

Ann is a senior HR professional with over 20 years’ experience ranging from FTSE 100 companies to start-ups and has experience in the biotech, manufacturing, chemical, technology and retail sectors.

Dr. Helen Bignell, Principal Scientist

Helen is highly experienced in technology development within the field of genomics, successfully taking innovative ideas to commercialised products. She holds a Master’s and a PhD in Molecular and Cell Biology. Previously Helen worked at Cambridge Epigenetix developing epigenetic tools to identify methylation in DNA. Prior to this Helen spent 10 years at Solexa/Illumina as a major contributor working on many aspects of the early NGS (Next Generation Sequencing) technology.

Dr. Mohamood Adhil, Data Science Team Leader

Adhil has extensive experience in extracting meaningful information from large biological and clinical datasets. He has a Master’s degree in Life Sciences Informatics and completed his PhD under the supervision of Prof. Marco Foiani, studying DNA supercoil role in genome organisation. Prior to joining Enhanc3D, Adhil was a product manager and data scientist at InterpretOmics, where he was responsible for the development of omics-based clinical software and knowledge bases tailored to enhance precision medicine.